Ayana Pharma

Ayana Pharma Ltd is a pharmaceutical company focused on developing liposomal therapies for cancer treatment. Founded in 2012 by Professor Chezy Barenholz (co-inventor of Doxil@, pegylated liposomal doxorubicin hydrochloride injection), its leading product LC101 (pegylated liposomal doxorubicin hydrochloride injection) has been approved by the FDA for the treatment of ovarian cancer, multiple myeloma, and AIDS-related conditions.